ロード中...
An Antiparasitic Compound from the Medicines for Malaria Venture Pathogen Box Promotes Leishmania Tubulin Polymerization
The few frontline antileishmanial drugs are poorly effective and toxic. To search for new drugs for this neglected tropical disease, we tested the activity of compounds in the Medicines for Malaria Venture (MMV) “Pathogen Box” against Leishmania amazonensis axenic amastigotes. Screening yielded six...
保存先:
| 出版年: | ACS Infect Dis |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8059355/ https://ncbi.nlm.nih.gov/pubmed/32686409 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsinfecdis.0c00122 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|